Drug–Drug Interactions Associated with Second-Generation Antipsychotics: Considerations for Clinicians and Patients

Name: Drug–Drug Interactions Associated with Second-Generation Antipsychotics: Considerations for Clinicians and Patients
SKU: 2334
Price: 30.00 USD
Availability: InStock

$30.00

Drug–Drug Interactions Associated with Second-Generation Antipsychotics: Considerations for Clinicians and Patients

By Robert R. Conley, MD and Deanna L. Kelly, PharmD, BCPP

Want a discount? Become a member by purchasing Psychopharmacology Bulletin Subscription - Individual!

Category: Medworks Reprint Series Tags: adverse-events, antipsychotic, cytochrome-p-450, drug-disposition, drug-interactions, hepatic, pharmacokinetics, psychotropic

Description

Description

Drug–Drug Interactions Associated with Second-Generation Antipsychotics: Considerations for Clinicians and Patients

By Robert R. Conley, MD and Deanna L. Kelly, PharmD, BCPP

CONLEY_REPRINT

Drug–Drug Interactions Associated with Second-Generation Antipsychotics: Considerations for Clinicians and Patients

Description

Antipsychotic Induced Symptomatic Hyperprolactinemia

Michael T. Compton, MD: Antipsychotic-Induced Hyperprolactinemia and Sexual Dysfunction

Pharmacokinetics, Drug Interactions, and Tolerability of Paroxetine and Paroxetine CR

Pharmacokinetics, Drug Interactions, and Tolerability of Valproate

Drug–Drug Interactions Associated with Second-Generation Antipsychotics: Considerations for Clinicians and Patients

Description

Related products

Antipsychotic Induced Symptomatic Hyperprolactinemia

Michael T. Compton, MD: Antipsychotic-Induced Hyperprolactinemia and Sexual Dysfunction

Pharmacokinetics, Drug Interactions, and Tolerability of Paroxetine and Paroxetine CR

Pharmacokinetics, Drug Interactions, and Tolerability of Valproate